Status:
COMPLETED
Development and Validation of (Bio)Sensors for the Identification of Pathogens
Lead Sponsor:
University of Bologna
Conditions:
Infections
Infection, Bacterial
Eligibility:
All Genders
18+ years
Brief Summary
The recent COVID-19 pandemic has revealed the need to develop tests that are accurate, rapid, and inexpensive for the diagnosis of infectious diseases. This problem is relevant not only for viruses, b...
Eligibility Criteria
Inclusion
- Obtaining informed consent
- Age ≥ 18 years
- Patients who meet one of the following conditions: SARS-CoV2 positive patients (group 1), SARS-CoV2 negative patients (group 2), P. aeruginosa positive patients (group 3), P. aeruginosa negative patients (group 4), L. infantum positive patients (group 5), L. infantum negative patients (group 6).
Exclusion
- None
Key Trial Info
Start Date :
May 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2025
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT06548841
Start Date
May 30 2024
End Date
October 31 2025
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical and Surgical Sciences, University of Bologna
Bologna, Bologna, Italy, 40138